Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of OPC-34712 and aripiprazole in hospitalized adults with acute schizophrenia
2009-012567-33Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in schizophrenia comparing OPC-34712, Aripiprazole and Placebo (3 arms). Primary endpoint: Change from baseline to Week 6/Early Termination in PANSS Total Score. Started Nov 2009; status: completed.
02
Drugs
brexpiprazolearipiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2009-012567-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012567-33.